Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodies: Author´s reply
- 1 April 2020
- journal article
- letter
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 74, 108-109
Abstract
No abstract availableFunding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (#2016/14172–6)
This publication has 12 references indexed in Scilit:
- Thrombocytopenia in primary antiphospholipid syndrome, a marker of high-risk patients?European Journal of Internal Medicine, 2020
- Clinical course of primary immune thrombocytopenia with positive antiphospholipid antibodiesEuropean Journal of Internal Medicine, 2019
- Thrombocytopenia in high‐risk patients with antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 2018
- Variability of cut‐off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform studyJournal of Thrombosis and Haemostasis, 2017
- Recurrent thrombosis in antiphospholipid syndrome may be associated with cardiovascular risk factors and inflammatory responseThrombosis Research, 2015
- The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical FeaturesAutoimmunity Reviews, 2015
- Variability and diagnostic utility of antiphospholipid antibodies including lupus anticoagulantsInternational Journal of Laboratory Hematology, 2013
- Update of the guidelines for lupus anticoagulant detectionJournal of Thrombosis and Haemostasis, 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006